» Articles » PMID: 32257209

UV Radiation Recruits CD4GATA3 and CD8GATA3 T Cells While Altering the Lipid Microenvironment Following Inflammatory Resolution in Human Skin

Overview
Date 2020 Apr 8
PMID 32257209
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Solar ultraviolet radiation (UVR) has major adverse effects on human health. While the mechanisms responsible for induction of UVR-induced inflammation are well-documented, the mediation of its resolution and longer-term adaptive homeostasis is unknown. Therefore, we examined the skin immune and lipid profile over time following UVR inflammation.

Methods: To investigate the self-resolving events of UVR inflammation , human skin was exposed to a single pro-inflammatory dose of UVR. Skin biopsies and suction blister fluid were taken at intervals up to 2 weeks post-UVR. The immune infiltrate was quantified by immunohistochemistry, and lipid mediators were profiled by liquid chromatography/mass spectrometry.

Results: We identified that cellular resolution events including switching of macrophage phenotype apply to human sunburn. However, UVR-induced inflammation in humans involves a post-resolution phase that differs from other experimental models. We demonstrate that 2 weeks after the initiating UVR stimulus, there is considerable immune activity with CD8GATA3 T cells maintained in human skin. Our results challenge the dogma of CD4FOXP3 T cells being the main effector CD4 T-cell population following UVR, with CD4GATA3 T cells the dominant phenotype. Furthermore, lipid mediators are elevated 14 days post-UVR, demonstrating the skin lipid microenvironment does not revert to the tissue setting occurring prior to UVR exposure.

Conclusion: We have identified for the first time that CD4GATA3 and CD8GATA3 T-cell subpopulations are recruited to UVR-inflamed human skin, demonstrating discrepancies between the adaptive UVR response in mice and humans. Future strategies to abrogate UVR effects may target these T-cell subpopulations and also the persistent alteration of the lipid microenvironment post-UVR.

Citing Articles

Adjuvant PD-1 Checkpoint Inhibition in Early Cutaneous Melanoma: Immunological Mode of Action and the Role of Ultraviolet Radiation.

Brandlmaier M, Hoellwerth M, Koelblinger P, Lang R, Harrer A Cancers (Basel). 2024; 16(8).

PMID: 38672543 PMC: 11047851. DOI: 10.3390/cancers16081461.


Ultraviolet exposure regulates skin metabolome based on the microbiome.

Patra V, Bordag N, Clement Y, Kofeler H, Nicolas J, Vocanson M Sci Rep. 2023; 13(1):7207.

PMID: 37137992 PMC: 10156686. DOI: 10.1038/s41598-023-34073-3.


The effects of exposure to solar radiation on human health.

Neale R, Lucas R, Byrne S, Hollestein L, Rhodes L, Yazar S Photochem Photobiol Sci. 2023; 22(5):1011-1047.

PMID: 36856971 PMC: 9976694. DOI: 10.1007/s43630-023-00375-8.


Single-cell RNA-seq reveals cellular heterogeneity from deep fascia in patients with acute compartment syndrome.

Wang T, Long Y, Ma L, Dong Q, Li Y, Guo J Front Immunol. 2023; 13:1062479.

PMID: 36741388 PMC: 9889980. DOI: 10.3389/fimmu.2022.1062479.


Role of distinct fibroblast lineages and immune cells in dermal repair following UV radiation-induced tissue damage.

Rognoni E, Goss G, Hiratsuka T, Sipila K, Kirk T, Kober K Elife. 2021; 10.

PMID: 34939928 PMC: 8747514. DOI: 10.7554/eLife.71052.


References
1.
Bais A, Lucas R, Bornman J, Williamson C, Sulzberger B, Austin A . Environmental effects of ozone depletion, UV radiation and interactions with climate change: UNEP Environmental Effects Assessment Panel, update 2017. Photochem Photobiol Sci. 2018; 17(2):127-179. PMC: 6155474. DOI: 10.1039/c7pp90043k. View

2.
Buckley C, Gilroy D, Serhan C . Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014; 40(3):315-27. PMC: 4004957. DOI: 10.1016/j.immuni.2014.02.009. View

3.
Rhodes L, Gledhill K, Masoodi M, Haylett A, Brownrigg M, Thody A . The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J. 2009; 23(11):3947-56. PMC: 2791058. DOI: 10.1096/fj.09-136077. View

4.
Fullerton J, Gilroy D . Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016; 15(8):551-67. DOI: 10.1038/nrd.2016.39. View

5.
Lucas R, Yazar S, Young A, Norval M, de Gruijl F, Takizawa Y . Human health in relation to exposure to solar ultraviolet radiation under changing stratospheric ozone and climate. Photochem Photobiol Sci. 2019; 18(3):641-680. DOI: 10.1039/c8pp90060d. View